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Summary
Plant genetic engineering is a powerful tool for producing crops resistant to pests, di-
seases and abiotic stress or crops with improved nutritional value or better quality pro-
ducts. Currently over 70 genetically modified (GM) crops have been approved for use in
different countries. These cover a wide range of plant species with significant number of
different modified traits. However, beside the technology used for their improvement, the
common component of most GM crops is the neomycin phosphotransferase II gene (nptII),
which confers resistance to the antibiotics kanamycin and neomycin. The nptII gene is pre-
sent in GM crops as a marker gene to select transformed plant cells during the first steps
of the transformation process. The use of antibiotic-resistance genes is subject to contro-
versy and intense debate, because of the likelihood that clinical therapy could be compro-
mised due to inactivation of the oral dose of the antibiotic from consumption of food deri-
ved from the transgenic plant, and because of the risk of gene transfer from plants to gut
and soil microorganisms or to consumer’s cells. The present article discusses these possibi-
lities in the light of current scientific knowledge.
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Introduction
Genetically modified (GM) crops are being devel-
oped for a variety of reasons, including resistance to
herbicides and pests, length of shelf-life in the case of
supermarket products, efficiency of processing, improv-
ed nutritional value etc. The success of these endeavours
is mostly determined by both the ability to deliver for-
eign genes in host plant cells and by the efficiency with
which transgenic plants can be regenerated from trans-
formed cells (1). When the gene of interest is transferred
to plant cell, one somehow has to identify the cells that
have taken up the additional genetic material. For that
purpose, the gene of interest is in most cases linked to a
selectable marker gene which confers antibiotic resistan-
ce. It allows efficient selection of transformed cells and
subsequent regeneration of transgenic plants. Therefore,
most GM crops that have been grown on 60 million ha
around the world (2) contain antibiotic resistance mar-
ker genes. The most commonly used marker gene is
neomycin phosphotransferase II gene (nptII), which con-
fers resistance to the antibiotics kanamycin and neomy-
cin. Some transgenic plants also contain antibiotic resis-
tance genes that are under the control of prokaryotic
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promoters, and therefore are not expressed in plant
cells. These are incorporated into plant genomes because
they are present on the same plasmid as the construct
used to transform plant cells and have been used for se-
lection in bacteria during gene cloning.
Standard safety evaluation of using any gene in-
cluding antibiotic resistance marker includes an assess-
ment of the safety of the protein encoded by the gene.
In case of antibiotic resistance genes, whether they are
expressed or not, experts have to answer to additional
questions that have become the subject of intense debate
(3): what are the therapeutic uses of the antibiotic that
the marker gene products inactivate and how widely
are they used? What is the likelihood that clinical the-
rapy could be compromised due to inactivation of the
oral dose of the antibiotic by consumption of food de-
rived from the transgenic plants? How prevalent is re-
sistance to these antibiotics among bacteria naturally
found in the gut or in the environment? What is the
likelihood that the therapeutic use of antibiotic could be
compromised from transfer of the antibiotic resistance
gene from food to gut epithelium with subsequent ex-
pression? What is the likelihood that antibiotic resis-
tance marker genes could be transferred from transgenic
plants to soil microorganisms with subsequent expres-
sion of the gene? How meaningful is the potential rate
of transfer of an antibiotic resistance gene to pathogenic
microorganisms thereby rendering them refractory to
the antibiotic? The issue is already covered by abundant
scientific literature including the opinions of different
scientific committees (3–9). The aim of this paper is to
summarise the issue in the light of the latest develop-
ments of the scientific knowledge.
Neomycin Phosphotransferase II Gene (nptII)
and Its Product
The antibiotic resistance marker gene nptII, which en-
codes aminoglycoside 3’-phosphotransferase II (APH(3’)II),
is one of the most widely used selectable marker genes
in plant genetic engineering. It was originally isolated as
a component of transposon Tn5 from the bacterium
Escherichia coli (10). The APH(3’)II, also called neomycin
phosphotransferase II (NPTII) or kanamycin phospho-
transferase II, is an enzyme that catalyzes the transfer of
a phosphate group from ATP to a hydroxyl group of
aminoglycoside antibiotics including neomycin, kana-
mycin, paromomycin, ribostamycin, gentamicins A and
B, as well as butirosins, thereby inactivating the antibi-
otics (3). Of the antibiotics that are inactivated by
APH(3’)II, only neomycin and kanamycin are currently
in therapeutic use for humans and animals (3).
Although the marker gene expression is required
only during the first steps of the plant transformation
process, it is driven by constitutive promoter and there-
fore the antibiotic inactivating enzyme is produced in all
the tissues and throughout the lifetime of the transgenic
plant. Since the nptII gene is routinely used as a select-
able gene in the production of transgenic plants, the
safety of the gene product has been the subject of many
investigations and evaluations which concluded that
APH(3’)II poses no risk to either humans, animals or the
environment (3,6,11–17). In these studies the potential
toxicity and allergenicity of the APH(3’)II have been in-
vestigated, as well as the probability that the presence of
APH(3’)II in food or feed would compromise the thera-
peutic efficiency of orally administrated antibiotics.
Potential Horizontal Transfer of the Plant
Derived nptII Gene to Soil or Intestinal
Microorganisms and to Consumer’s Cells
Transfer of plant DNA fragments to microbial or
mammalian cells would require the following steps
(6,7):
¿ survival of the released DNA fragments in an aggres-
sive environment
¿ uptake of the DNA fragments by microbial or mam-
malian cells
¿ DNA taken up should be stably established in the re-
cipient cells
¿ the establishment should at least be neutral otherwise
the recipient cells are counter-selected
Fate of the DNA released in soil
Free plant DNA is released into soil by decaying
plant material. The persistence of free DNA in soil is af-
fected by different abiotic and biotic factors. However,
after cell death plant DNA is protected from degrada-
tion by cell wall for some time (18). Additionally, the
content and type of clay minerals influence the extent to
which free DNA is adsorbed to mineral surface and,
thus, protected from degradation by nucleases (19– 22).
Therefore, large amounts of extracellular DNA are
readily found in most soils and persist for months or
even years, indicating that the turnover of naturally re-
leased extracellular DNA is quite slow (23–27). Since
plant DNA can persist adsorbed on soil particles or pro-
tected by plant cell wall, competent bacteria colonising
in close vicinity could take up this DNA. In addition, for
those bacteria that have developed specific symbiotic or
pathogenic relationships with plants, conditions for
gene transfer could be even more favourable (28–31).
Natural transformation of soil bacteria
Natural genetic transformation is a process by which
bacteria are able to take up and integrate exogenous free
DNA from their environment. This process enables the
recipient organisms to acquire novel genes or heritable
traits. Although numerous reports indicated that hori-
zontal gene transfer events would be very rare in the
environment it has effectively changed the ecological
and pathogenic character of bacterial species (19,32–35).
It is estimated that an average soil bacterial commu-
nity contains 109 cells/g of soil belonging to 2000–18 000
distinct genomes (36–39). Although relatively few spe-
cies have been shown to carry the genes required to de-
velop a natural state of competence (33), their number
could be significantly higher considering that more than
99 % of all soil bacteria remain uncultured in vitro (40).
Selective screening of soil bacteria from field trials
of genetically modified plants containing antibiotic re-
sistance marker genes have shown no bacterial transfor-
mants (26,27,41). In addition, several groups have failed
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to detect horizontal gene transfer from transgenic plants
to bacteria under laboratory conditions (42–44). How-
ever, uptake of transgenic plant DNA fragments by bac-
teria based on restoration of a partially deleted nptII
gene after recombination with transgenic plant homolo-
gues has been demonstrated in various conditions (45–
50). De Vries and Wackernagel (45) studied the ability of
the opportunistic soil bacterium Acinetobacter sp. strain
BD413 to take up and integrate transgenic plant DNA
under the optimised laboratory conditions. The assay
was based on the recombinational repair of an nptII
gene with an internal 10-bp deletion located on a plas-
mid downstream of a bacterial promoter. When compe-
tent Acinetobacter sp. BD413 cells containing the mutant
nptII gene on a plasmid were transformed with DNA
from various transgenic plants (potato, tomato, sugar
beet, oilseed rape and tobacco) carrying nptII as a mar-
ker gene the kanamycin-resistant transformants were
obtained (45). Similar observations were also made us-
ing transgenic sugar beet DNA and sugar beet homo-
genates for transformation of Acinetobacter strain BD413
carrying nptII gene with 317-bp deletion on a plasmid
(46). Both groups showed that the bacterium could ac-
cess plant DNA under optimised in vitro conditions if
homologous stretches of DNA were present, but studies
done under optimised in vitro conditions sometimes
have little relevance to natural systems such as soil.
However, Nielsen et al. (47) showed that horizontal
transfer of DNA, extracted from transgenic sugar beets,
to bacteria, based on homologous recombination, can
occur in soil. They demonstrated that restoration of a
317-bp-deleted nptII gene on plasmid in Acinetobacter sp.
strain BD413 cells could be obtained in sterile soil mi-
crocosms after addition of nutrients and transgenic
plant DNA encoding a functional nptII gene. In a similar
assay Tepfer et al. (50) obtained kanamycin-resistant
transformants of Acinetobacter sp. strain BD413 in sterile
soil without addition of nutrients. Since competent cells
prepared in vitro were used in both above studies, it
should be considered that the Acinetobacter sp. strain
BD413 is unable to develop competence when grown in
soil (40), and that competence is lost very rapidly in situ
when competent cells are inoculated into soil (51). How-
ever, Demaneche et al. (40) found that two other bacteria
species also present in most soils (Agrobacterium tumefa-
ciens and Pseudomonas fluorescens) were able to take up
replicating plasmid in their natural environment, soil
microcosms, without any specific physical or chemical
treatment. Interestingly, P. fluorescens produced transfor-
mants in both sterile and nonsterile soil microcosms but
failed to do so in various in vitro conditions. Therefore,
the actual status leading to a physical, chemical, physio-
logical, or genetic induction of competence in A.
tumefaciens and P. fluorescens in soil remained unknown.
Concerning natural conditions that might allow soil bac-
teria to take up DNA from the environment, it has been
shown recently that thunderstorms and lightning dis-
charges might play important role in that process (52).
The Escherichia coli strain DH10B has been efficiently
transformed with replicating plasmid in soil microcosms
only after the soil was subjected to laboratory-scale
lightning that had an electrical field gradient and cur-
rent density similar to those of full-scale lightning. Al-
though E. coli is not a soil bacterium the universality of
this process needs to be considered since the cells from
nearly all bacterial taxa can be electroporated in the lab-
oratory more or less efficiently and independently of
their physiological state and with transforming DNA of
prokaryotic or eukaryotic origin (52). In addition, it has
been demonstrated that Acinetobacter sp. strain BD413
developed a competence state in planta during the active
colonisation of Ralstonia solanacearum-infected plants (30,
53). The study was performed with transplastomic to-
bacco plants (transgene aadA that confers resistance to
spectinomycin and streptomycin was integrated into
chloroplast genome). The Acinetobacter sp. cells carrying
a plasmid containing tobacco plastid sequences were
transformed by the plant's transgene (aadA) during co-
infection of transplastomic tobacco plant with R. solana-
cearum. However, no transformants were observed when
the homologous sequences to the chloroplast genome
were omitted from the Acinetobacter sp. plasmid (30).
The results of all studies dealing with the transfer of
plant transgenes to soil bacteria by natural transforma-
tion have shown that the main limitation to such events
would be related to the presence of homology between
foreign DNA and recipient genom (45–50). For instance,
competent cells of the soil bacteria Pseudomonas stutzeri
and Acinetobacter sp. BD413 (both harbouring a plasmid
with an nptII gene containing a small deletion) were
transformed with the same efficiency with an nptII gene
whether it was present in the genome of transgenic po-
tato or on plasmid DNA. However, in the absence of
homologous sequences in the recipient cells the transfor-
mation by nptII dropped by at least about 108-fold in P.
stutzeri and 109-fold in Acinetobacter resulting in the lat-
ter strain in  1 · 10–13 transformants per nptII (48). This
indicates a very low probability of non-homologous
DNA fragments to be integrated by illegitimate recom-
bination events during transformation (48). Working
also with the nptII gene, de Vries and Wackernagel (49)
found that the integration of nonhomologous foreign
DNA into the genome of the Acinetobacter sp. BD413
during transformation indeed was at least 109-fold lower
than that of homologous DNA, but the integration of
nonhomologous foreign DNA increased at least 105-fold
when it was linked on one side to a piece of DNA ho-
mologous to the recipient genome. This homology-facili-
tated illegitimate recombination decreased with decreas-
ing homology length but was still measurable at 183 bp
(49).
The presented data indicate that gene transfer from
transgenic plants to soil bacteria could occur under nat-
ural conditions at least when certain homologous se-
quences are shared between transgene and the DNA of
the recipient cell. Studies on transfer of nptII gene and
other antibiotic resistance marker genes have revealed
that the transfer of a marker gene from a genetically
modified plant to soil bacteria that do not already con-
tain the same resistance gene is extremely unlikely.
Even in case a kanamycin sensitive soil bacterium ac-
quires plant derived nptII gene the spread of the new
trait in the bacterial population would depend on com-
petitive (selective) advantage of any transformed cells.
As the occurrence of kanamycin in natural soil has not
yet been detected, Nielsen et al. (47) have suggested that
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natural soil conditions would rarely produce the selec-
tive pressure required for fixation of possible transfers
of the nptII gene from transgenic plants into the recipi-
ent bacterium. On the other side, kanamycin-resistant
bacteria are abundant in natural soils (29,45,47,54). For
instance, de Vries and Wackernagel (45) examined the
DNA extracted from four soil samples taken in different
areas on farm land and all four samples contained DNA
that could be amplified by nptII-specific PCR primers.
The concentration of the target nptII sequence varied be-
tween 2 · 105 and 3 · 108 molecules/g of soil (dry
weight). Therefore, under the worst-case assumptions,
kanamycin-resistant transformants resulting from plant
DNA left in the fields would represent not more than
one in 10 million of the existing kanamycin-resistance
soil population (3).
Fate of the DNA released in the intestinal tract of
mammals and birds
To address the possibility that bacteria or epithelial
cells of gastrointestinal tract may take up and integrate
diet-derived DNA fragments, the stability of DNA in all
regions of the digestive system must be taken into con-
sideration.
Dietary intakes of nucleic acids in humans depend
on the origin of the diet and will vary widely between
individuals but are typically in the range of 0.1–1 g/per-
son/day (41). The oral cavity is the site of first contact
between the incoming food-derived DNA and the resi-
dent bacteria and it is one of the most complex and he-
terogenous microbial habitats in the human body. Mer-
cer et al. (55) investigated the survival of plasmid DNA
in human saliva in vitro. Competitive PCR was used to
monitor the survival of a 520-bp DNA target sequence
from a plasmid after admixture of the plasmid with
freshly sampled human saliva from five subjects. The
fraction of the target remaining amplifiable ranged from
40–65 % after 10 min and from 6–25 % after 60 min of
exposure to saliva (55). Recently, the survival of GM
soybean transgenes during the passage through the
complete gastrointestinal tract of humans has been eval-
uated (54). To track DNA survival through the small in-
testine seven ileostomists were given a single meal con-
taining commercial GM soybean (the meal, consisting of
454 g wet weight, contained 3·1012 copies of the trans-
gene), and the appearance of the transgene DNA on the
digesta collected from the stoma was monitored by
competitive PCR. Whilst the amount of the transgene
that survived the passage from the small bowel was
highly variable between subjects, the nucleic acid was
detected in all seven subjects (in one individual as much
as 3.7 % of the 180 bp fragment of transgene DNA was
recovered at the stoma). The survival of endogenous
soybean lectin gene was also monitored and the results
showed that the transgene degraded at a rate similar to
the bulk soybean DNA. In parallel investigation 12 hu-
man volunteers with an intact gastrointestinal tract were
fed the same meal and no transgene DNA was detected
in the faeces indicating that the nucleic acid did not sur-
vive the passage through the complete intestine (54).
Investigations in animals suggest that after duode-
num passage, over 95 % of DNA is hydrolysed and the
bases are absorbed into the enterocyte (41). Duggan et
al. (56) examined the survival of plasmid carrying a
transgene of commercially available maize as well as
transgenic maize DNA in ovine oral cavity. Densitome-
try and spectrophotometric determinations showed that
at least 70 % of the plasmid DNA taken in the mouth
was lost within the first minute, and samples recovered
after 10 min contained only 10 % of the original plasmid
DNA concentration. The physical integrity of maize
chromosomal DNA was similarly destroyed within 1
min of the addition to the oral cavity. However, PCR ex-
periments designed to estimate the persistence of target
sequences from plasmid DNA following incubation in
the oral cavity indicated that both the 1914-bp and the
214-bp fragment could be amplified from saliva-degrad-
ed plasmid, even after 30 min of incubation. PCR ampli-
fication of the 1914-bp target from maize chromosomal
DNA was, however, only possible for up to 5 min of ex-
posure to the oral cavity, whereas a shorter, 211-bp tar-
get sequence was still available for amplification after 30
min (56). Duggan et al. (56) also used PCR to investigate
the survival of transgenic maize DNA in the rumen of
sheep fed silage and maize grains. A 1914-bp DNA frag-
ment containing the entire coding region of the trans-
gene was still amplifiable from rumen fluid sampled 5 h
after feeding maize grains. The same target sequence,
however, could not be amplified from rumen fluid sam-
pled from sheep fed silage prepared from the same GM
maize line. PCR amplification of a shorter (211-bp) tar-
get sequence was possible with rumen fluid sampled up
to 3 and 24 h after feeding silage and maize grains, re-
spectively. Schubert et al. (57) demonstrated in mice fed
phage M13mp18 DNA (7250 bp) that about 1–2 % of
orally ingested DNA persisted transiently in fragments
between 100 and 400 bp in size (and rarely fragments
up to 1700 bp). The small intestine contained about 2.2–
0.7 % (1–8 h after feeding), the cecum 2.4–1.1 % (2–18 h)
and the large intestine 0.2–1.7 % (2–8 h) of the phage
DNA administered orally (57). Chambers et al. (58) ex-
amined the survival of the ampicillin resistance marker
gene throughout the chicken gastrointestinal tract (broi-
ler chicken were fed commercial transgenic maize mate-
rial). Samples of digesta collected from the crop, stom-
ach, small intestine, large intestine, cecum and rectum
were analysed by PCR. Plant derived marker gene was
found in the crop of all five birds examined and in the
stomach of two birds, but not in the rest of the tract.
However, under the same experimental conditions the
wild-type ampicillin resistance gene present in the intes-
tinal microflora was readily detected in all the parts of
gastrointestinal tract whether the chickens were fed
transgenic or conventional maize material (58).
Natural transformation of gastrointestinal bacteria
The data presented above demonstrate that food-de-
rived DNA fragments of various sizes could be detected
in different parts of gastrointestinal tract of mammals
and birds. Since the concentration of bacteria is high
e.g. 1012 cells/cm3 in human colon, 1011 cells/cm3 in ru-
men (5,59), the gastrointestinal tract could be very con-
ducive to horizontal gene transfer events if resident bac-
teria are capable of transformation in that environment.
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Mercer et al. (55,60) showed that the oral bacterium
Streptococcus gordonii DL1 could be transformed in vitro
by replicating and non-replicating plasmid in the pres-
ence of human saliva, implying that naturally transfor-
mable bacteria could successfully take up DNA frag-
ments released in human oral cavity. However, the
transformation with non-replicating plasmid was ob-
tained only when homology to bacterial chromosomal
sequences was provided (60). Additionally, it has been
demonstrated that another oral bacterium Streptococcus
mutans can be transformed in biofilm, its natural envi-
ronment (61). It has also been found that a small pro-
portion of the indigenous intestinal microflora of ileo-
stomists fed transgenic soybean acquired a food derived
transgen, but the authors were unable to isolate those
bacteria by colony blot hybridisation or a PCR pooling
strategy (54). Duggan et al. (62) successfully transformed
competent E. coli DH5 cells in filter-sterilised ovine ru-
men fluid with replicating plasmid containing ampicillin
resistance gene. However, the significance of this inves-
tigation should be considered under the light of the fol-
lowing facts: bacteria E. coli is a minor constituent of the
resident microflora of the rumen (representing some
105/cm3 cells in the rumen of healthy adult cattle and
sheep) and the population levels of E. coli strains carry-
ing transmissible multiple antibiotic resistance can reach
104/cm3 cells in the rumen of sheep maintained under
common dietary conditions (62).
The presented data indicate that naturally compe-
tent residents of gastrointestinal tract of mammals and
birds could be transformed with food-derived DNA
fragments, especially if the homology between exoge-
nous DNA and recipient cell is provided or when exog-
enous fragments are part of replicating plasmids. The
studies on natural transformation of soil bacteria are
also relevant to horizontal gene transfer in the gut since
many soil organisms are carried into the gut with food
especially fresh fruits and vegetables. However, the con-
tribution of plant derived kanamycin resistance gene is
expected to be extremely small since genes for resistance
to kanamycin already occur quite commonly in the ani-
mal gut microflora e.g. the flora of the human gut natu-
rally contains about 1012 kanamycin resistant bacteria
(11). It has been calculated that consumption of GM to-
mato containing nptII gene would lead to a maximum
projected increase in the number of kanamycin resistant
bacteria in the human gut of 2.6 · 10–13 % (14). Further-
more, antibiotic resistance genes occurring naturally in
gastrointestinal flora are often associated with highly
mobile genetic elements like conjugative plasmids and
transposons (e.g. nptII gene was originally isolated as a
component of transposon Tn5 from the gastrointestinal
bacterium E. coli) that are readily mobilizable between
taxa and represent the most common method of acquir-
ing antibiotic resistance determinants among bacteria.
Thus, the practical impact of the transfer of kanamycin
resistance gene from GM plants to gastrointestinal bac-
teria would be negligible.
Transfer of diet derived DNA to animal cells
Another concern associated with food derived from
GM crops is the possibility that transgenes might beco-
me incorporated into the consumer’s genetic make-up.
A number of studies have examined the take-up of
DNA by mammalian cells from the diet. Schubert et al.
(57) demonstrated that phage DNA fragments orally ad-
ministered to mice were taken up by intestinal wall epi-
thelia and reached the nuclei of leukocytes as well as
spleen and liver cells. The isolation of recombinant clo-
nes suggested that phage DNA fragments were cova-
lently linked to mouse DNA. Later studies in mice
showed that diet derived DNA could be found in the
foetuses and newborn mice of pregnant mice consuming
large amount of naked DNA fragments (63). This DNA
was found in the nuclei but never in all of the cells of
the foetus suggesting a transplacental pathway rather
than germline transmission (63). In both studies discus-
sed above a large amount of the naked DNA was fed to
mice. However, similar results were obtained when the
fate of plant specific nucleus encoded gene was follow-
ed in mice after feeding them with soybean leaves – a
337-bp fragment was detectable by PCR in DNA from
liver and spleen (64). Klotz and Einspanier (65) reported
the detection of chloroplast DNA fragment in white
blood cells of a cow fed a diet containing GM soybean,
but under the same experimental conditions the detec-
tion of transgene fragment in white blood cells was un-
successful. Plant DNA was not found in the milk either
(65). Similarly, in a more recent study ten Holstein/Frie-
sian cows receiving up to 26.1 % of GM soybean in their
diet did not have detectable amounts of transgene DNA
in their milk (66). In a study of cattle and chickens fed
GM maize under normal feeding conditions, it was
found that only short DNA fragments (<200 bp) derived
from chloroplasts could be detected in the blood lym-
phocytes of cows (67). In all other cattle organs investi-
gated (muscle, liver, spleen, kidney) plant DNA was not
found although there were faint traces in milk. How-
ever, in all chicken tissues (muscle, liver, spleen, kidney)
the short maize chloroplast gene fragment was detected,
but not in eggs. In contrast, fragments originating from
the soybean transgene were not detected in any of the
cattle or poultry samples (67). The same strategy was
used to study a possible transfer of residual chloroplast
specific DNA as well as transgene fragments of GM
maize into different pig organs (blood, muscle, liver,
spleen and lymph nodes) after feeding pigs with con-
ventional and GM maize (68). Although short chloro-
plast DNA fragments (199 bp) were successfully ampli-
fied from the intestinal juices of pigs up to 12 h after the
last feeding, neither chloroplast-specific DNA nor trans-
gene specific fragments were detected in any pig tissue
investigated (68). A field study examining supermarket
poultry samples (leg, stomach, breast and wing muscle)
led to frequent detections of the short (199 bp) chloro-
plast DNA fragment. Furthermore, faint signals for the
maize specific zein gene fragment were detected in
these poultry tissues (68). Additional PCR examinations
using unhatched chicken embryos showed that neither
chloroplast nor maize genes were present endogenously
within the wild-type poultry genome indicating that
only a transient transfer of short forage DNA into most
poultry organs could be suspected (68).
The presented studies indicate that depending on
the animal species and the type of food, a more or less
significant transfer of foreign food DNA into some types
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of consumer's cells can be assumed, especially if the
amount of specific DNA in food is large (e.g. organelle
derived DNA). Since throughout evolution living beings
have been confronted by huge amounts of food derived
DNA an uptake of certain amounts of foreign gene ma-
terial must be accepted as a normal event for man and
other animals. Various hypotheses have been proposed
on how foreign DNA can reach the mammalian organ-
ism through gastrointestinal or placental portals, and
which consequences should be considered (41,64,67,69).
Today no safe indication for the biological relevance of
highly degraded DNA can be provided to prove an in-
teraction with consumers health – although it seems to
be very unlikely that functional genes are transferred by
this process (67). However, DNA derived from GM crops
is equivalent to DNA which has always been consumed
with human diets, so any risks from the consumption of
GM crops are, per gene and per passage through the
gastrointestinal tract, the same as those from the con-
sumption of any DNA since all DNA is handled by the
body in the same way. Furthermore, most of the genes
used for the genetic modification of food and feed or-
ganisms including nptII gene come from organisms for
which there is a long history of human and animal ex-
posure.
Conclusions
The nptII gene, which confers resistance to the anti-
biotics kanamycin and neomycin, is the most widely
used antibiotic resistance marker gene in plant genetic
engineering. Although the transfer of nptII gene from
GM plants to soil and gastrointestinal bacteria or to con-
sumer’s cells has to overcome a series of hurdles, the ex-
perimental approaches have demonstrated that each of
the steps required can be achieved in nature. At the
same time the data show that when both a homology
between transgene and recipient genome and selection
pressure are not present the chances of transfer to bacte-
ria are extremely low. Furthermore, the nptII gene is al-
ready present in very large amounts among the soil and
gastrointestinal bacteria (carried by easily exchangeable
genetic elements), meaning that humans and animals
are permanently exposed to the nptII gene whether they
consume GM or non-GM plants. Therefore, the practical
impact of both the consumption of GM plants contain-
ing nptII gene by humans or animals and of the transfer
of nptII gene from GM plants to gastrointestinal or soil
bacteria would be negligible.
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Rasprave o genu za otpornost na antibiotik kanamicin,
zajedni~koj zna~ajki ve}ine transgenih biljaka
Sa`etak
Primjenom geneti~kog in`enjerstva u oplemenjivanju biljaka dobivene su kulture ot-
porne na nametnike, bolesti i druge nepovoljne ~initelje okoli{a, kao i one pobolj{anih
prehrambenih i drugih svojstava. Trenuta~no se u svijetu uzgaja vi{e od 70 sorata biljaka
oplemenjenih geneti~kim in`enjerstvom (geneti~ki modificirane kulture – GM kulture),
koje obuhva}aju brojne vrste s razli~itim zna~ajkama. Me|utim, osim tehnologije primije-
njene u njihovu oplemenjivanju, ve}ini GM biljaka zajedni~ki je gen za neomicin-fosfotran-
sferazu II (nptII), koji odre|uje otpornost na antibiotike kanamicin i neomicin. Gen nptII
189S. JELENI] et al.: Kanamycin Resistance Marker Gene in Transgenic Plants, Food Technol. Biotechnol. 41 (2) 183–190 (2003)
koristi se u biljnom geneti~kom in`enjerstvu radi olak{anog izdvajanja transformiranih sta-
nica u po~etnoj fazi postupka. Primjena gena za otpornost na antibiotike u biljnom gene-
ti~kom in`enjerstvu tema je mnogobrojnih rasprava zbog mogu}nosti inaktivacije oralno
apliciranih antibiotika u potro{a~a geneti~ki modificiranih biljaka, te zbog rizika horizon-
talnog prijenosa gena za otpornost na antibiotike iz GM biljaka u mikroorganizme tla i
probavnoga sustava, te prijenosa u stanice potro{a~a. U radu se raspravlja o tim rizicima u
vezi s najnovijim znanstvenim spoznajama.
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